Deaths in South Korea After Flu Vaccinations Shouldn ’t Stop Flu Shot Campaigns
Four dozen people in South Korea have died after recently receiving their seasonal flu shots, but health officials there say the deaths were not related to the vaccinations.
South Korean health officials found no direct link between the deaths and the flu shots and plan to continue the country’s immunization campaign to vaccinate people for free. “After reviewing death cases so far, it is not the time to suspend a flu vaccination program since vaccination is very crucial this year, considering … the COVID-19 outbreak,” Jeong Eun-Kyung, director of the Korea Disease Control Agency, said during a bri...
Source: TIME: Health - October 26, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Is this the answer for threatening allergic reactions?
The transparent wafer, which is placed under the tongue at the first sign of a dangerous allergic reaction (called anaphylaxis), could stop life-threatening allergic reactions in their tracks. (Source: the Mail online | Health)
Source: the Mail online | Health - September 29, 2020 Category: Consumer Health News Source Type: news
Cases of Nut Anaphylaxis Spike in Children at Halloween and Easter Cases of Nut Anaphylaxis Spike in Children at Halloween and Easter
The number of children showing up in emergency departments with anaphylaxis may spike during Halloween and Easter, a new study suggests.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 25, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
Holidays Can Be a Fright for Kids With Food Allergies
A new study found that serious allergic reactions (anaphylaxis) triggered by peanuts jumped 85% when kids were trick or treating. (Source: WebMD Health)
Source: WebMD Health - September 21, 2020 Category: Consumer Health News Source Type: news
Peanut-, Tree Nut-Induced Anaphylaxis Up on Halloween, Easter
MONDAY, Sept. 21, 2020 -- Among Canadian children, the risk for anaphylaxis induced by unknown nuts and peanuts is increased during Halloween and Easter, according to a study published online Sept. 21 in CMAJ, the journal of the Canadian Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 21, 2020 Category: Pharmaceuticals Source Type: news
Holidays Can Be a Fright for Kids With Food Allergies
MONDAY, Sept. 21, 2020 -- Parents of kids with food allergies probably won ' t be surprised to hear that Halloween is an especially risky time for their youngsters.
A new study found that serious allergic reactions (anaphylaxis) triggered by peanuts... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 21, 2020 Category: General Medicine Source Type: news
Epinephrine in Anaphylaxis: Too Little, Too Late Epinephrine in Anaphylaxis: Too Little, Too Late
Epinephrine is the recommended treatment for anaphylaxis, yet it is routinely underutilized among both patients and clinicians. What strategies may help increase the usage of this life-saving drug?Current Opinion in Allergy and Clinical Immunology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 15, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology Journal Article Source Type: news
What is the Allergen Cross-Reactivity Rate of Legumes?
Discussion
There are 8 common foods which compromise 90% of food allergens with those being peanuts, soybeans, cow’s milk, eggs, fish, crustacean/shellfish, wheat and tree nuts. Some people believe that lupin (a legume) is 9th.
Legumes belong to the Fabaceae family. They provide protein, fat, vitamins other essential nutrients and therefore are used in the human diet throughout the world.
“[A]llergenicity due to consumption of legumes in decreasing order may be peanut, soybean, lentil, chickpea, pea, mung bean and red gram.” Other common legumes include alfalfa, clovers, beans, lupins, mesquite, carob...
Source: PediatricEducation.org - September 14, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Therapy helps children with food allergies manage severe anxiety
(Children's Hospital of Philadelphia) Children's Hospital of Philadelphia (CHOP) has launched the Food Allergy Bravery (FAB) Clinic to help children with a phobia of anaphylaxis. This revolutionary clinic, housed within the Food Allergy Center, is the first in the world to bring together psychologists and food allergy experts to treat food allergic children with severe phobia of anaphylaxis. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 28, 2020 Category: International Medicine & Public Health Source Type: news
Subcutaneous Daratumumab Combination Resulted in Deep and Rapid Hematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, NJ, June 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the first randomized Phase 3 study investigating subcutaneous daratumumab[i] in the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare and potentially fatal disease.[1],[2] The data demonstrated subcutaneous daratumumab in combination with cyclophosphamide, bortezomib, and dexamethasone (D-CyBorD) resulted in a higher hematologic complete response rate (CR), (53 percent vs. 18 percent [P<0.0001]), compared to CyBorD. Additionally, treatment with D-CyBorD delayed the time ...
Source: Johnson and Johnson - June 15, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Pill to Prevent Anaphylaxis May Be on the Horizon
Pills used to treat blood cancers may potentially prevent life-threatening allergic reactions, early research hints. (Source: WebMD Health)
Source: WebMD Health - June 11, 2020 Category: Consumer Health News Source Type: news
Coronavirus Pandemic May Change Care For Some Allergy Patients After Severe Reactions
Designed to ease the fear of Covid-19 at hospital emergency rooms, a modified plan for food allergy-induced anaphylaxis calls for home management with epinephrine autoinjectors in certain scenarios. It's a case of shared decisionmaking in a pandemic. But the alternative plan isn't for everyone. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 5, 2020 Category: Pharmaceuticals Authors: Kristen Gerencher, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
An Adolescent Girl With Symptoms of Anaphylaxis An Adolescent Girl With Symptoms of Anaphylaxis
This 14-year-old girl with a history of weight loss and food allergies presented with symptoms of anaphylaxis, but allergy and immunological workup were negative. What was the real etiology?Journal of Medical Case Reports (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 22, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology Journal Article Source Type: news
New longer-term data reinforce safety of Roche ’s satralizumab in adults and adolescents with neuromyelitis optica spectrum disorder
Basel, 22 May 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new pooled pivotal satralizumab safety results for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating central nervous system disorder. These data are being presented at the 6th Annual Meeting of the European Academy of Neurology (EAN) and show satralizumab was well-tolerated in a broad patient population – including adolescents, for whom there is no approved medicine. Satralizumab is an investigational humanised monoclonal antibody that targets the interleukin-6 (IL-6) receptor, believed to play a key role in the infla...
Source: Roche Media News - May 22, 2020 Category: Pharmaceuticals Source Type: news
New longer-term data reinforce safety of Roche ’s satralizumab in adults and adolescents with neuromyelitis optica spectrum disorder
Basel, 22 May 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new pooled pivotal satralizumab safety results for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating central nervous system disorder. These data are being presented at the 6th Annual Meeting of the European Academy of Neurology (EAN) and show satralizumab was well-tolerated in a broad patient population – including adolescents, for whom there is no approved medicine. Satralizumab is an investigational humanised monoclonal antibody that targets the interleukin-6 (IL-6) receptor, believed to play a key role in the infla...
Source: Roche Investor Update - May 22, 2020 Category: Pharmaceuticals Source Type: news
